The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Markham Richard J since year 2005.
The trader's CIK number is 1362743.
At the time of this reporting, Markham Richard J is the Director of Nephrogenex, Inc. .
(stock ticker symbol NRX).
See this page for all insider trading activities at Nephrogenex, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2010-03-05||ACUR||Acura Pharmaceuticals, Inc||Sale||10,923||4.77||52,102|
|2009-05-22||ACUR||Acura Pharmaceuticals, Inc||Sale||5,800||7.50||43,500|
|2009-05-26||ACUR||Acura Pharmaceuticals, Inc||Sale||10,000||7.38||73,800|
|2009-05-20||ACUR||Acura Pharmaceuticals, Inc||Sale||6,000||7.34||44,040|
|2009-05-15||ACUR||Acura Pharmaceuticals, Inc||Sale||1,338||7.04||9,419|
|2009-05-13||ACUR||Acura Pharmaceuticals, Inc||Sale||7,028||7.05||49,547|
|2009-05-07||ACUR||Acura Pharmaceuticals, Inc||Sale||12,900||6.91||89,139|
|2009-05-08||ACUR||Acura Pharmaceuticals, Inc||Sale||10,600||6.93||73,458|
|2009-05-06||ACUR||Acura Pharmaceuticals, Inc||Sale||12,100||6.79||82,159|
|2009-03-24||ACUR||Acura Pharmaceuticals, Inc||Sale||35,000||7.11||248,850|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Markham Richard J (Director of Nephrogenex, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.